RxDoctor Payments DataLook up a doctor →

Melissa Rhodes, MD

Sleep Medicine · Cartersville, GANPI 1396743308

Payments from drug & device makers

$14,173in general payments, 2019–2025

Across 579 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$3K
  • GSK$2K
  • AstraZeneca$1K
  • Jazz Pharmaceuticals Inc.$1K
  • Grifols USA, LLC$709
  • Mallinckrodt Hospital Products Inc.$591
  • plus $5K from 41 others

What the payments were for

  • Consulting fees$2,35017%
  • Food & beverage$11,70083%
  • Education$1231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,173 in reported general payments places this provider in the 80th percentile of 50 sleep medicine providers in Georgia.

See all sleep medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$452,214
Medicare patients
584
Services billed
7,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter343$306,748
OfevNintedanib Esylate22$286,411
NucalaMepolizumab26$92,067
Breo ElliptaFluticasone/Vilanterol108$67,566
Stiolto RespimatTiotropium Br/Olodaterol Hcl89$61,068
Advair HfaFluticasone Propion/Salmeterol86$50,622
Spiriva RespimatTiotropium Bromide66$48,781
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr56$40,529
SymbicortBudesonide/Formoterol Fumarate106$35,165
Arnuity ElliptaFluticasone Furoate75$26,919
Breztri AerosphereBudesonide/Glycopyr/Formoterol32$25,883
XolairOmalizumab16$24,340
Spiriva HandihalerTiotropium Bromide29$23,991
BelsomraSuvorexant37$23,468
Fluticasone-SalmeterolFluticasone Propion/Salmeterol64$19,265

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta$1,751$543,676624 claims
Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat$2,991$396,260177 claims
AstraZenecaSymbicort, Breztri Aerosphere$1,441$61,048138 claims
MerckBelsomra, Dulera$235$32,61865 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$166$4,69412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 50 sleep medicine providers in Georgia.

Other sleep medicine in Cartersville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →